EDSA Edesa Biotech Inc

Price (delayed)

$3.97

Market cap

$38.27M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.69

Enterprise value

$27.94M

?
Relative Growth: Rel. Growth: 1
Relative Strength: Rel. Strength: 78
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 0

Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company developing innovative ways to treat inflammatory and immune-related diseases. Its clinical pipeline is focused on two therapeutic areas: Medical Dermatology and Respiratory. ...

Highlights
EDSA's net income has dropped by 138% year-on-year and by 35% since the previous quarter
The quick ratio has shrunk by 86% YoY and by 42% QoQ

Key stats

What are the main financial stats of EDSA

EDSA stock price

How has the Edesa Biotech stock price performed over time
Intraday
-2.46%
1 week
2.58%
1 month
-10.38%
1 year
66.81%
YTD
179.58%
QTD
-51.17%

Financial performance

How have Edesa Biotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$14.63M
Net income
-$14.1M
Gross margin
N/A
Net margin
N/A
EDSA's net income has dropped by 138% year-on-year and by 35% since the previous quarter
Edesa Biotech's operating income has plunged by 127% YoY and by 33% from the previous quarter

Price vs fundamentals

How does EDSA's price correlate with its fundamentals

Growth

What is Edesa Biotech's growth rate over time

Valuation

What is Edesa Biotech stock price valuation
P/E
N/A
P/B
4.01
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Edesa Biotech's EPS has decreased by 28% YoY and by 26% from the previous quarter
The equity has declined by 38% year-on-year and by 14% since the previous quarter
EDSA's price to book (P/B) is 21% higher than its 5-year quarterly average of 3.4 and 11% higher than its last 4 quarters average of 3.7

Efficiency

How efficient is Edesa Biotech business performance
The company's return on equity has shrunk by 78% YoY and by 51% QoQ
Edesa Biotech's return on assets has shrunk by 75% YoY and by 40% QoQ

Dividends

What is EDSA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EDSA.

Financial health

How did Edesa Biotech financials performed over time
The quick ratio has shrunk by 86% YoY and by 42% QoQ
EDSA's current ratio has shrunk by 85% YoY and by 42% QoQ
EDSA's debt is 100% smaller than its equity
The equity has declined by 38% year-on-year and by 14% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.